Cargando…
Immunohistochemical Expression of BCL-2 in Endometrial Carcinoma and Its Comparison With Hormone Receptor Status and Epidermal Growth Factor
Background: Endometrial carcinoma is the most common malignant tumor of the female genital tract with increasing incidence in developed countries. In the era of targeted therapy, immunohistochemical markers play an important role in the treatment and prognosis of endometrial carcinoma. The aim of th...
Autores principales: | Kandaswamy, Sharanya, Palanisamy, Poongothai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896848/ https://www.ncbi.nlm.nih.gov/pubmed/36751174 http://dx.doi.org/10.7759/cureus.33346 |
Ejemplares similares
-
Immunohistochemical Evaluation of S100, Alpha-Smooth Muscle Actin, Podoplanin, Matrix Metalloproteinase 13, and Human Epidermal Growth Factor Receptor 2neu Markers in Basal Cell Carcinoma Variants
por: Jabour, Shatha A, et al.
Publicado: (2022) -
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003) -
Expression of Sex Hormones in Oral Squamous Cell Carcinoma: A Systematic Review on Immunohistochemical Studies
por: R, Saranya, et al.
Publicado: (2022) -
Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome
por: Munawar, Shahzeb, et al.
Publicado: (2021) -
Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
por: Alves, Fátima R, et al.
Publicado: (2022)